These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19497053)

  • 1. Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities.
    Nordvall M; Dziegiel M; Hegaard HK; Bidstrup M; Jonsbo F; Christensen B; Hedegaard M
    Transfusion; 2009 Oct; 49(10):2070-5. PubMed ID: 19497053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
    Tormey CA; Fisk J; Stack G
    Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
    Schonewille H; van de Watering LM; Brand A
    Transfusion; 2006 Apr; 46(4):630-5. PubMed ID: 16584440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B; Schonewille H; van de Watering L; Brand A
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female alloimmunization with antibodies known to cause hemolytic disease.
    Geifman-Holtzman O; Wojtowycz M; Kosmas E; Artal R
    Obstet Gynecol; 1997 Feb; 89(2):272-5. PubMed ID: 9015034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility.
    Smith HM; Shirey RS; Thoman SK; Jackson JB
    Immunohematology; 2013; 29(4):127-30. PubMed ID: 24689681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
    Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
    Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of red blood cell alloantibody in Kuwaiti population.
    Ameen R; Al-Eyaadi O; Al-Shemmari S; Chowdhury R; Al-Bashir A
    Med Princ Pract; 2005; 14(4):230-4. PubMed ID: 15961931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The characterization and classification of concurrent blood group antibodies.
    Tormey CA; Stack G
    Transfusion; 2009 Dec; 49(12):2709-18. PubMed ID: 19682334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetomaternal hemorrhage following funipuncture: increase in severity of maternal red-cell alloimmunization.
    Bowman JM; Pollock JM; Peterson LE; Harman CR; Manning FA; Menticoglou SM
    Obstet Gynecol; 1994 Nov; 84(5):839-43. PubMed ID: 7936523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies.
    Schonewille H; Doxiadis II; Levering WH; Roelen DL; Claas FH; Brand A
    Transfusion; 2014 Aug; 54(8):1971-80. PubMed ID: 24654685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden.
    Gottvall T; Filbey D
    Acta Obstet Gynecol Scand; 2008; 87(8):843-8. PubMed ID: 18704776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Diego a red blood cell alloantibody as a possible cause of anemia in a 3-week-old infant.
    Hundric-Haspl Z; Balen-Marunic S; Tomasic-Susanj E; Tomicic M; Vujaklija-Stipanovic K
    Arch Med Res; 2003; 34(2):149-51. PubMed ID: 12700013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for blood grouping and red cell antibody testing during pregnancy. British Committee for Standards in Haematology, Blood Transfusion Task Force.
    Transfus Med; 1996 Mar; 6(1):71-4. PubMed ID: 8696452
    [No Abstract]   [Full Text] [Related]  

  • 19. Red blood cell alloimmunization in pregnancy during the years 1996-2015 in Iceland: a nation-wide population study.
    Bollason G; Hjartardottir H; Jonsson T; Gudmundsson S; Kjartansson S; Halldorsdottir AM
    Transfusion; 2017 Nov; 57(11):2578-2585. PubMed ID: 28840609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specificity and clinical features of erythrocytic allo-antibodies in hospitalized patients].
    Wu BT; Yao DG; Rong RM
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1691-3. PubMed ID: 21914318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.